Articles with public access mandates - Dean NaisbittLearn more
Not available anywhere: 36
Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug‐specific T cells
B Daubner, M Groux‐Keller, OV Hausmann, T Kawabata, DJ Naisbitt, ...
Allergy 67 (1), 58-66, 2012
Mandates: Swiss National Science Foundation
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis
RE Jenkins, FS Yaseen, MM Monshi, P Whitaker, X Meng, J Farrell, ...
Chemical research in toxicology 26 (6), 963-975, 2013
Mandates: UK Medical Research Council
The importance of hapten–protein complex formation in the development of drug allergy
L Faulkner, X Meng, BK Park, DJ Naisbitt
Current opinion in allergy and clinical immunology 14 (4), 293-300, 2014
Mandates: UK Medical Research Council, European Commission
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer
VE Shaw, DJ Naisbitt, E Costello, W Greenhalf, BK Park, JP Neoptolemos, ...
Expert review of vaccines 9 (9), 1007-1016, 2010
Mandates: Cancer Research UK
Drug‐specific CD4+ T‐cell immune responses are responsible for antituberculosis drug‐induced maculopapular exanthema and drug reaction with eosinophilia …
YM Ye, GY Hur, SH Kim, GY Ban, YK Jee, DJ Naisbitt, HS Park, SH Kim
British Journal of Dermatology 176 (2), 378-386, 2017
Mandates: UK Medical Research Council
Auto-oxidation of isoniazid leads to isonicotinic-lysine adducts on human serum albumin
X Meng, JL Maggs, T Usui, P Whitaker, NS French, DJ Naisbitt, BK Park
Chemical research in toxicology 28 (1), 51-58, 2015
Mandates: UK Medical Research Council
Human leukocyte antigen and idiosyncratic adverse drug reactions
T Usui, DJ Naisbitt
Drug metabolism and pharmacokinetics 32 (1), 21-30, 2017
Mandates: UK Medical Research Council
Identification of flucloxacillin-haptenated HLA-B* 57: 01 ligands: evidence of antigen processing and presentation
JC Waddington, X Meng, PT Illing, A Tailor, K Adair, P Whitaker, J Hamlett, ...
Toxicological Sciences 177 (2), 454-465, 2020
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs
DJ Naisbitt, RG Nattrass, MO Ogese
Immunology and Allergy Clinics 34 (3), 691-705, 2014
Mandates: UK Medical Research Council
Abacavir forms novel cross-linking abacavir protein adducts in patients
X Meng, AS Lawrenson, NG Berry, JL Maggs, NS French, DJ Back, ...
Chemical research in toxicology 27 (4), 524-535, 2014
Mandates: UK Medical Research Council
Dapsone and nitroso dapsone activation of naı̈ve T-cells from healthy donors
A Alzahrani, M Ogese, X Meng, JC Waddington, A Tailor, J Farrell, ...
Chemical research in toxicology 30 (12), 2174-2186, 2017
Mandates: UK Medical Research Council
Characterization of peroxidases expressed in human antigen presenting cells and analysis of the covalent binding of nitroso sulfamethoxazole to myeloperoxidase
MO Ogese, RE Jenkins, JL Maggs, X Meng, P Whitaker, D Peckham, ...
Chemical Research in Toxicology 28 (1), 144-154, 2015
Mandates: UK Medical Research Council
In Vitro Priming of Naı̈ve T-cells with p-Phenylenediamine and Bandrowski’s Base
A Gibson, SH Kim, L Faulkner, J Evely, M Pirmohamed, KB Park, ...
Chemical Research in Toxicology 28 (10), 2069-2077, 2015
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Definition of haptens derived from sulfamethoxazole: in vitro and in vivo
A Tailor, JC Waddington, J Hamlett, J Maggs, L Kafu, J Farrell, GJ Dear, ...
Chemical research in toxicology 32 (10), 2095-2106, 2019
Mandates: UK Medical Research Council
New approaches to investigate drug-induced hypersensitivity
MO Ogese, S Ahmed, A Alferivic, CJ Betts, A Dickinson, L Faulkner, ...
Chemical research in toxicology 30 (1), 239-259, 2017
Mandates: National Health and Medical Research Council, Australia, UK Biotechnology …
Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B:*: 57: 01-restricted CD8:+: T-cell activation
DJ Naisbitt, EL Yang, M Alhaidari, NG Berry, AS Lawrenson, J Farrell, ...
Aids 29 (18), 2385-2395, 2015
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Drug‐specific T‐cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat
PJ Thomson, L Kafu, X Meng, J Snoeys, A De Bondt, D De Maeyer, H Wils, ...
Allergy 76 (6), 1825-1835, 2021
Mandates: UK Medical Research Council
HLA DRB1* 15: 01-DQB1* 06: 02-restricted human CD4+ T cells are selectively activated with amoxicillin-peptide adducts
A Tailor, X Meng, K Adair, J Farrell, JC Waddington, A Daly, ...
Toxicological Sciences 178 (1), 115-126, 2020
Mandates: UK Medical Research Council
Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA‐B* 57: 01 binding and T‐cell activation
PJ Thomson, PT Illing, J Farrell, M Alhaidari, CC Bell, N Berry, PM O’Neill, ...
Allergy 75 (3), 636-647, 2020
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?
A Sullivan, A Gibson, BK Park, DJ Naisbitt
Expert Opinion on Drug Metabolism & Toxicology 11 (3), 357-368, 2015
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Publication and funding information is determined automatically by a computer program